Shares of Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $12.0312, but opened at $12.3860. Santen Pharmaceutical shares last traded at $12.3860, with a volume of 440 shares.
Santen Pharmaceutical Stock Down 1.1%
The stock has a 50 day moving average price of $12.52 and a two-hundred day moving average price of $11.65.
About Santen Pharmaceutical
Santen Pharmaceutical Co, Ltd. is a Japan?based specialty pharmaceutical company focused exclusively on ophthalmology. Headquartered in Osaka, Santen engages in the research, development, manufacture and marketing of prescription and over?the?counter products for the diagnosis and treatment of eye diseases. Its core product portfolio includes therapies for glaucoma, dry eye, retinal disorders, uveitis and post?operative care, as well as surgical equipment and diagnostic agents designed to support comprehensive eye care.
With roots tracing back to the late 19th century, Santen has grown from a domestic manufacturer to a global ophthalmic specialist.
Recommended Stories
- Five stocks we like better than Santen Pharmaceutical
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
